Diagnosis and management of bronchiolitis

Allan S. Lieberthal, Howard Bauchner, Caroline B. Hall, David W. Johnson, Uma Kotagal, Michael J. Light, Wilbert Mason, H. Cody Meissner, Kieran J. Phelan, Joseph J. Zorc, Mark A Brown, Richard D. Clover, Ian T. Nathanson, Matti Korppi, Richard N. Shiffman, Danette Stanko-Lopp, Caryn Davidson

Research output: Contribution to journalArticle

734 Citations (Scopus)

Abstract

Bronchiolitis is a disorder most commonly caused in infants by viral lower respiratory tract infection. It is the most common lower respiratory infection in this age group. It is characterized by acute inflammation, edema, and necrosis of epithelial cells lining small airways, increased mucus production, and bronchospasm. The American Academy of Pediatrics convened a committee composed of primary care physicians and specialists in the fields of pulmonology, infectious disease, emergency medicine, epidemiology, and medical informatics. The committee partnered with the Agency for Healthcare Research and Quality and the RTI International-University of North Carolina Evidence-Based Practice Center to develop a comprehensive review of the evidence-based literature related to the diagnosis, management, and prevention of bronchiolitis. The resulting evidence report and other sources of data were used to formulate clinical practice guideline recommendations. This guideline addresses the diagnosis of bronchiolitis as well as various therapeutic interventions including bronchodilators, corticosteroids, antiviral and antibacterial agents, hydration, chest physiotherapy, and oxygen. Recommendations are made for prevention of respiratory syncytial virus infection with palivizumab and the control of nosocomial spread of infection. Decisions were made on the basis of a systematic grading of the quality of evidence and strength of recommendation. The clinical practice guideline underwent comprehensive peer review before it was approved by the American Academy of Pediatrics. This clinical practice guideline is not intended as a sole source of guidance in the management of children with bronchiolitis. Rather, it is intended to assist clinicians in decision-making. It is not intended to replace clinical judgment or establish a protocol for the care of all children with this condition. These recommendations may not provide the only appropriate approach to the management of children with bronchiolitis.

Original languageEnglish (US)
Pages (from-to)1774-1793
Number of pages20
JournalPediatrics
Volume118
Issue number4
DOIs
StatePublished - Oct 2006
Externally publishedYes

Fingerprint

Bronchiolitis
Practice Guidelines
Respiratory Tract Infections
Infectious Disease Medicine
Pediatrics
Respiratory Syncytial Virus Infections
Medical Informatics
Bronchial Spasm
Pulmonary Medicine
Peer Review
Emergency Medicine
Evidence-Based Practice
Information Storage and Retrieval
Health Services Research
Bronchodilator Agents
Primary Care Physicians
Mucus
Child Care
Cross Infection
Antiviral Agents

Keywords

  • Bronchiolitis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Lieberthal, A. S., Bauchner, H., Hall, C. B., Johnson, D. W., Kotagal, U., Light, M. J., ... Davidson, C. (2006). Diagnosis and management of bronchiolitis. Pediatrics, 118(4), 1774-1793. https://doi.org/10.1542/peds.2006-2223

Diagnosis and management of bronchiolitis. / Lieberthal, Allan S.; Bauchner, Howard; Hall, Caroline B.; Johnson, David W.; Kotagal, Uma; Light, Michael J.; Mason, Wilbert; Meissner, H. Cody; Phelan, Kieran J.; Zorc, Joseph J.; Brown, Mark A; Clover, Richard D.; Nathanson, Ian T.; Korppi, Matti; Shiffman, Richard N.; Stanko-Lopp, Danette; Davidson, Caryn.

In: Pediatrics, Vol. 118, No. 4, 10.2006, p. 1774-1793.

Research output: Contribution to journalArticle

Lieberthal, AS, Bauchner, H, Hall, CB, Johnson, DW, Kotagal, U, Light, MJ, Mason, W, Meissner, HC, Phelan, KJ, Zorc, JJ, Brown, MA, Clover, RD, Nathanson, IT, Korppi, M, Shiffman, RN, Stanko-Lopp, D & Davidson, C 2006, 'Diagnosis and management of bronchiolitis', Pediatrics, vol. 118, no. 4, pp. 1774-1793. https://doi.org/10.1542/peds.2006-2223
Lieberthal AS, Bauchner H, Hall CB, Johnson DW, Kotagal U, Light MJ et al. Diagnosis and management of bronchiolitis. Pediatrics. 2006 Oct;118(4):1774-1793. https://doi.org/10.1542/peds.2006-2223
Lieberthal, Allan S. ; Bauchner, Howard ; Hall, Caroline B. ; Johnson, David W. ; Kotagal, Uma ; Light, Michael J. ; Mason, Wilbert ; Meissner, H. Cody ; Phelan, Kieran J. ; Zorc, Joseph J. ; Brown, Mark A ; Clover, Richard D. ; Nathanson, Ian T. ; Korppi, Matti ; Shiffman, Richard N. ; Stanko-Lopp, Danette ; Davidson, Caryn. / Diagnosis and management of bronchiolitis. In: Pediatrics. 2006 ; Vol. 118, No. 4. pp. 1774-1793.
@article{746d66d362e04440950b9d4867edd57a,
title = "Diagnosis and management of bronchiolitis",
abstract = "Bronchiolitis is a disorder most commonly caused in infants by viral lower respiratory tract infection. It is the most common lower respiratory infection in this age group. It is characterized by acute inflammation, edema, and necrosis of epithelial cells lining small airways, increased mucus production, and bronchospasm. The American Academy of Pediatrics convened a committee composed of primary care physicians and specialists in the fields of pulmonology, infectious disease, emergency medicine, epidemiology, and medical informatics. The committee partnered with the Agency for Healthcare Research and Quality and the RTI International-University of North Carolina Evidence-Based Practice Center to develop a comprehensive review of the evidence-based literature related to the diagnosis, management, and prevention of bronchiolitis. The resulting evidence report and other sources of data were used to formulate clinical practice guideline recommendations. This guideline addresses the diagnosis of bronchiolitis as well as various therapeutic interventions including bronchodilators, corticosteroids, antiviral and antibacterial agents, hydration, chest physiotherapy, and oxygen. Recommendations are made for prevention of respiratory syncytial virus infection with palivizumab and the control of nosocomial spread of infection. Decisions were made on the basis of a systematic grading of the quality of evidence and strength of recommendation. The clinical practice guideline underwent comprehensive peer review before it was approved by the American Academy of Pediatrics. This clinical practice guideline is not intended as a sole source of guidance in the management of children with bronchiolitis. Rather, it is intended to assist clinicians in decision-making. It is not intended to replace clinical judgment or establish a protocol for the care of all children with this condition. These recommendations may not provide the only appropriate approach to the management of children with bronchiolitis.",
keywords = "Bronchiolitis",
author = "Lieberthal, {Allan S.} and Howard Bauchner and Hall, {Caroline B.} and Johnson, {David W.} and Uma Kotagal and Light, {Michael J.} and Wilbert Mason and Meissner, {H. Cody} and Phelan, {Kieran J.} and Zorc, {Joseph J.} and Brown, {Mark A} and Clover, {Richard D.} and Nathanson, {Ian T.} and Matti Korppi and Shiffman, {Richard N.} and Danette Stanko-Lopp and Caryn Davidson",
year = "2006",
month = "10",
doi = "10.1542/peds.2006-2223",
language = "English (US)",
volume = "118",
pages = "1774--1793",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "4",

}

TY - JOUR

T1 - Diagnosis and management of bronchiolitis

AU - Lieberthal, Allan S.

AU - Bauchner, Howard

AU - Hall, Caroline B.

AU - Johnson, David W.

AU - Kotagal, Uma

AU - Light, Michael J.

AU - Mason, Wilbert

AU - Meissner, H. Cody

AU - Phelan, Kieran J.

AU - Zorc, Joseph J.

AU - Brown, Mark A

AU - Clover, Richard D.

AU - Nathanson, Ian T.

AU - Korppi, Matti

AU - Shiffman, Richard N.

AU - Stanko-Lopp, Danette

AU - Davidson, Caryn

PY - 2006/10

Y1 - 2006/10

N2 - Bronchiolitis is a disorder most commonly caused in infants by viral lower respiratory tract infection. It is the most common lower respiratory infection in this age group. It is characterized by acute inflammation, edema, and necrosis of epithelial cells lining small airways, increased mucus production, and bronchospasm. The American Academy of Pediatrics convened a committee composed of primary care physicians and specialists in the fields of pulmonology, infectious disease, emergency medicine, epidemiology, and medical informatics. The committee partnered with the Agency for Healthcare Research and Quality and the RTI International-University of North Carolina Evidence-Based Practice Center to develop a comprehensive review of the evidence-based literature related to the diagnosis, management, and prevention of bronchiolitis. The resulting evidence report and other sources of data were used to formulate clinical practice guideline recommendations. This guideline addresses the diagnosis of bronchiolitis as well as various therapeutic interventions including bronchodilators, corticosteroids, antiviral and antibacterial agents, hydration, chest physiotherapy, and oxygen. Recommendations are made for prevention of respiratory syncytial virus infection with palivizumab and the control of nosocomial spread of infection. Decisions were made on the basis of a systematic grading of the quality of evidence and strength of recommendation. The clinical practice guideline underwent comprehensive peer review before it was approved by the American Academy of Pediatrics. This clinical practice guideline is not intended as a sole source of guidance in the management of children with bronchiolitis. Rather, it is intended to assist clinicians in decision-making. It is not intended to replace clinical judgment or establish a protocol for the care of all children with this condition. These recommendations may not provide the only appropriate approach to the management of children with bronchiolitis.

AB - Bronchiolitis is a disorder most commonly caused in infants by viral lower respiratory tract infection. It is the most common lower respiratory infection in this age group. It is characterized by acute inflammation, edema, and necrosis of epithelial cells lining small airways, increased mucus production, and bronchospasm. The American Academy of Pediatrics convened a committee composed of primary care physicians and specialists in the fields of pulmonology, infectious disease, emergency medicine, epidemiology, and medical informatics. The committee partnered with the Agency for Healthcare Research and Quality and the RTI International-University of North Carolina Evidence-Based Practice Center to develop a comprehensive review of the evidence-based literature related to the diagnosis, management, and prevention of bronchiolitis. The resulting evidence report and other sources of data were used to formulate clinical practice guideline recommendations. This guideline addresses the diagnosis of bronchiolitis as well as various therapeutic interventions including bronchodilators, corticosteroids, antiviral and antibacterial agents, hydration, chest physiotherapy, and oxygen. Recommendations are made for prevention of respiratory syncytial virus infection with palivizumab and the control of nosocomial spread of infection. Decisions were made on the basis of a systematic grading of the quality of evidence and strength of recommendation. The clinical practice guideline underwent comprehensive peer review before it was approved by the American Academy of Pediatrics. This clinical practice guideline is not intended as a sole source of guidance in the management of children with bronchiolitis. Rather, it is intended to assist clinicians in decision-making. It is not intended to replace clinical judgment or establish a protocol for the care of all children with this condition. These recommendations may not provide the only appropriate approach to the management of children with bronchiolitis.

KW - Bronchiolitis

UR - http://www.scopus.com/inward/record.url?scp=33750132530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750132530&partnerID=8YFLogxK

U2 - 10.1542/peds.2006-2223

DO - 10.1542/peds.2006-2223

M3 - Article

C2 - 17015575

AN - SCOPUS:33750132530

VL - 118

SP - 1774

EP - 1793

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 4

ER -